EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review

Erdenetsogt Dungubat iD, Kohei Fujikura, Masahiko Kuroda iD, Toshio Fukusato, Yoshihisa Takahashi iD

Nutrients · 03.07.2025 · 17 (13) · 2211

DOI: 10.3390/nu17132211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 03.07.2025. Verfasst von Erdenetsogt Dungubat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan. Hauptthemen laut MEDLINE: Nutrients, Fatty Liver, Phytochemicals, Metabolic Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS Kakenhi, Japan Society for the Promotion of Science (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are growing global health concerns. However, pharmacological therapies for MASLD/MASH have not yet been established. Dietary interventions and their bioactive components have been explored as strategies to mitigate MASLD and MASH progression. Although specific nutrients and bioactive compounds have exhibited potential therapeutic benefits, they also exacerbate adverse outcomes. In this comprehensive review, we synthesize the protective and exacerbating or sometimes dual effects of key macronutrients, including fatty acids (saturated, unsaturated, and trans fats) and carbohydrates (fructose, glucose, and sucrose), and bioactive compounds and micronutrients, in the context of MASLD management. The evidence suggests that coffee-derived compounds, such as caffeine and chlorogenic acid, may attenuate liver injury. However, the effects on MASLD severity are inconsistent. Diets high in saturated fatty acids exacerbate MASLD pathogenesis, whereas moderate intake (7–10% of total energy) may confer metabolic benefits. Other bioactive compounds and micronutrients have been explored for their diverse roles in hepatic lipid metabolism and insulin sensitivity. Although current evidence supports the therapeutic potential of specific dietary nutrients and bioactive compounds in the management of MASLD, inconsistencies in results highlight the need for more robust, well-controlled studies, including clinical trials, to clarify the preventive and therapeutic standards for balanced food interventions in MASLD management. In particular, well-designed clinical trials are necessary before clinical application. Although this is a narrative review and the literature retrieval may be biased, we covered a wide variety of substances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NutrientsFatty LiverPhytochemicalsMetabolic DiseasesDietNon-alcoholic Fatty Liver DiseaseHumansMicronutrients

Stichwörter der Autor:innen

dietary interventionfatty acidliver fibrosismetabolic dysfunction-associated steatohepatitismetabolic dysfunction-associated steatotic liver diseasenutritionpolyphenolvitaminzinc

Substanzen

NutrientsMicronutrientsPhytochemicals

Autor:innen und Institutionen

  • Department of Molecular Pathology, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan.
  • General Medical Education and Research Center, Teikyo University, Itabashi-ku, Tokyo 173-8605, Japan.

ORCID-Profile: Erdenetsogt Dungubat, Masahiko Kuroda, Yoshihisa Takahashi

Förderung

  • JSPS Kakenhi
  • Japan Society for the Promotion of Science (JSPS) KAKENHI

Zitieren

APA

Dungubat, E., Fujikura, K., Kuroda, M., Fukusato, T., & Takahashi, Y. (2025). Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review. Nutrients, 17(13), 2211. https://doi.org/10.3390/nu17132211

Vancouver

Dungubat E, Fujikura K, Kuroda M, Fukusato T, Takahashi Y. Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review. Nutrients. 2025;17(13):2211. doi:10.3390/nu17132211

BibTeX
@article{Dungubat2025,
  author = {Dungubat, Erdenetsogt and Fujikura, Kohei and Kuroda, Masahiko and Fukusato, Toshio and Takahashi, Yoshihisa},
  title = {Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2211},
  doi = {10.3390/nu17132211}
}
Kostenlos starten →